Undifferentiated carcinoma of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
5
|
|
0.300 |
None |
|
0 |
|
|
|
Gastric Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
453
|
235
|
0.300 |
None |
|
0 |
1
|
|
|
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.110 |
None |
1.000 |
2 |
1
|
2016 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
26 |
|
2007 |
2020 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.100 |
None |
1.000 |
23 |
|
2010 |
2020 |
Carcinoma, Neuroendocrine
|
disease |
Neoplasms
|
Neoplastic Process
|
182
|
7
|
0.100 |
None |
1.000 |
10 |
|
2016 |
2019 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Iron binding capacity total measurement
|
phenotype |
|
Laboratory Procedure
|
20
|
35
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Maculopapular Lesion
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases
|
Finding
|
16
|
28
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
308
|
454
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1215
|
339
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Secondary malignant neoplasm of colon and/or rectum
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
397
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Spastic Paraplegia, Hereditary
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
123
|
41
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Paraparesis, Spastic
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
75
|
37
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Total iron binding capacity function
|
phenotype |
|
Clinical Attribute
|
20
|
35
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Spastic Paraplegia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
144
|
93
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
MYOPATHY, MYOFIBRILLAR, 7
|
disease |
|
Disease or Syndrome
|
2
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Neuroendocrine tumor G2 (NET G2)
|
disease |
|
Neoplastic Process
|
5
|
|
0.090 |
None |
1.000 |
9 |
|
2017 |
2019 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.070 |
None |
0.857 |
7 |
|
2007 |
2018 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.060 |
None |
1.000 |
6 |
|
2008 |
2019 |
Multiple Endocrine Neoplasia Type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
145
|
156
|
0.060 |
None |
1.000 |
6 |
|
2009 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.060 |
None |
0.833 |
6 |
|
2011 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.060 |
None |
0.833 |
6 |
|
2011 |
2020 |